Menu
← Oncology Approval Tracker
FDA DECISION ·
Fludarabine Phosphate Injection
fludarabine phosphate · Sandoz
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with B-cell chronic lymphocytic leukemia as part of combination therapy, or after lack of response or progression during at least one alkylator-containing regimen.
LAMPGEN ANALYSIS
Why it matters
The Project Renewal update added a combination indication and aligned the older label with the evidence for use with cyclophosphamide and rituximab.
What research teams should watch
Review order sets against the updated combination schedule and carry forward infection, marrow and transfusion precautions.
PRIMARY RECORDS